Dachaigh › Leukemia Lymphocytic Cronach › Sgìre Cholumbia › Washington
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Washington, DC
Tha 22 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mìle air falbh
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
A’ fastadhÌre 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7 mìle air falbh
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
A’ fastadhSgrùdadh amharc
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
A’ fastadhÌre 3
- GC2202 Study Site 111, Bethesda · 7 mìle air falbh
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
A’ fastadhÌre 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A’ fastadhÌre 3
- American Oncology Partners of Maryland Pa, Bethesda · 7 mìle air falbh
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
A’ fastadhÌre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A’ fastadhÌre 2
- Maryland Oncology Hematology, Silver Spring · 7 mìle air falbh
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
A’ fastadhÌre 1 tràth
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A’ fastadhÌre 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mìle air falbh
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
A’ fastadhÌre 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7 mìle air falbh
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
A’ fastadhÌre 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- National Institute of Health, Bethesda · 7 mìle air falbh
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A’ fastadhÌre 2
- American Oncology Partners, PA, Bethesda · 7 mìle air falbh
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A’ fastadhÌre 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7 mìle air falbh
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7 mìle air falbh
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN18 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
- Nashville, TN13 sgrùdaidhean
Sgrùdaidhean eile ann an Washington
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag55 sgrùdaidhean
- Aillse a' bhroilleach46 sgrùdaidhean
- Ailse metastatach43 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Aillse Prostata38 sgrùdaidhean
- Obesity33 sgrùdaidhean
- Aillse colorectal29 sgrùdaidhean
- Galarachd Cardiovasculach28 sgrùdaidhean
- Aillse sa bhlaire26 sgrùdaidhean
- Leukemia myeloid geur24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.